Evaluation of the estimation of midazolam concentrations and pharmacokinetic parameters in intensive care patients using a bayesian pharmacokinetic software (PKS) according to sparse sampling approach

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 6, 2003, Pages 765-771

  Bolon, M ^a,b   Bastien, O ^b   Flamens, C ^b   Paulus, S ^b   Salord, F ^c   Boulieu, R ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b LOUIS PRADEL HOSPITAL   (France)

^c HÔPITAL NEUROLOGIQUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BILIRUBIN; CARBAMAZEPINE; CREATININE; ERYTHROMYCIN; FLUCONAZOLE; MIDAZOLAM;

ADULT; AGED; ARTICLE; BAYES THEOREM; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INFUSION; FEMALE; HUMAN; INTENSIVE CARE; MALE; MULTIPLE ORGAN FAILURE; PHARMACOLOGICAL PARAMETERS; PREDICTION; RANK SUM TEST; SEDATION; VALIDATION PROCESS;

AREA UNDER CURVE; BAYES THEOREM; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; INTENSIVE CARE; MALE; METABOLIC CLEARANCE RATE; MIDAZOLAM; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SOFTWARE;

EID: 0037530382     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/002235703765951366     Document Type: Article

References (17)

1. Bressolle, F., Bologna, C., Edno, L., Bernard, J. C., Gomeni, R., Sany, J., Combe, B. (1996) A limited sampling method to estimate methotrexate pharmacokinetics in patients with rheumatoid arthritis using a bayesian approach and the population data modeling program P-PHARM. Eur. J. Clin. Pharmacol. 49: 285-292
2. Burtin, P., Jacqz-Aigrain, E., Girard, P., Lenclen, R., Magny, J. F., Betremieux, P., Tehiry, C., Desplanques, L., Mussat, P. (1994) Population pharmacokinetics of midazolam in neonates. Clin. Pharmacol. Ther. 56: 615-625
3. Dundee, J. W., Halliday, N. J., Harper, K. W., Brogden, R. N. (1984) Midazolam: A review of its pharmacological properties and therapeutic use. Drugs 28: 519-543
4. Gaulier, J. M., Boulieu, R., Fischer, C., Mauguiere, F. (1997) Predictions of carbamazepine concentrations using a Bayesian program (PKS System, Abbott): A retrospective evaluation in an outpatient population. J. Pharm. Pharmacol. 49: 734-736
5. Kinowski, J. M., Rodier, M., Bressolle, F., Fabre, D., Augey, V., Richard, J. L., Galtier, M., Gomeni, R. (1995) Bayesian estimation of p-aminohippurate clearance by a limited sampling strategy. J. Pharm. Sci. 84: 307-311
6. Lee, T. C., Charles, B. G., Harte, G. J., Gray, P. H., Steer, P. A., Flenady, V. J. (1999) Population pharmacokinetic modeling in very premature infants receiving midazolam during mechanical ventilation. Anesthesiology 90: 451-457
7. Lehmann, B., Boulieu, R. (1995) Determination of midazolam and its unconjugated 1-hydroxy metabolite in human plasma by high-performance liquid chromatography. J. Chromatogr. 674: 138-142
8. Malacrida, R., Fritz, M. E., Suter, P. M., Crevoisier, C. (1992) Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Crit. Care Med. 20: 1123-1126
9. Michalk, S., Moncorge, C., Fichelle, A., Huot, O., Servin, F., Farinotti, R., Desmonts, J. M. (1988) Midazolam infusion for basal sedation in intensive care: Absence of accumulation. Intensive Care Med. 15: 37-41
10. Polard, E., Le Bouquin, V., Le Corre, P., Kerebel, C., Trout, H., Feuilu, A., Leverge, R., Malledant, Y. (1999) Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients. Ther. Drug. Monit. 21: 395-403
11. Power, B. M., Forbes, A. M., Van Heerden, P. V., Ilett, K. F. (1993) Pharmacokinetics of drugs used in critically ill adults. Clin. Pharmacokinet. 24: 362-379
12. Sheiner, L. B., Beal, S. L. (1981) Some suggestions for measuring predictive performance. J. Pharmacokinet. Biopharm. 9: 503-512
13. Shelly, M. P., Mendel, L., Park, G. R. (1987) Failure of critically ill patients to metabolise midazolam. Anaesthesia 42: 619-626
14. Shelly, M. P., Sultan, M. A., Bodenham, A., Park, G. R. (1991) Midazolam infusion in critically ill patients. Eur. J. Anaesthesiol. 8: 21-27
15. Vree, T. B., Shimoda, M., Driessen, J. J., Guelen, P. J. M., Janssen, T. J., Termond, E. F. S., Van Dalen, R., Hafkenscheid, J. C., Dirksen, M. S. (1989) Decreased plasma albumin concentrations results in increased volume of distribution and decreased elimination of midazolam in intensive care patients. Clin. Pharmacol. Ther. 46: 537-544
16. Wu, G., Baraldo, M., Pea, F., Cossettini, P., Furlanut, M. (1995) Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by bayesian and non-linear least square methods. Pharmacol. Res. 32: 355-362
17. Zomorodi, K., Donner, A., Somma, J., Barr, J., Sladen, R., Ramsay, J., Geller, E., Shafer, S. L. (1998) Population pharmacokinetics of midazolam administered by target controlled infusion for sedation following coronary artery bypass grafting. Anesthesiology 89: 1418-1429